Applications of Ethyl 2,3-Dibromobutyrate in Industrial Manufacturing

Our expertise as a leading producer of Ethyl 2,3-Dibromobutyrate supports advanced manufacturing needs by supplying this specialty intermediate to core downstream sectors with well-established technical requirements. We maintain a precise focus on application environments where this raw material substantiates proven benefits in synthesis or modification steps, guided by verified protocols and leading industry standards. Explore the principal industrial scenarios in which our product empowers controlled, value-added integration.

1. Pharmaceutical Intermediate Synthesis

Ethyl 2,3-Dibromobutyrate functions as a precision alkylating and halogenation agent in the manufacture of selected active pharmaceutical ingredients (APIs), especially for substituted butyrate frameworks used in anticonvulsant and cardiovascular compounds. Many contract manufacturing organizations and drug substance producers utilize this raw material during the multi-stage assembly of molecules requiring a dibrominated motif, capitalizing on its controlled reactivity and ease of subsequent functionalization. Quality assurance routines regularly reference its impact on intermediate purity and impurity profile during synthesis, with process chemists adjusting input rates according to stoichiometric demand and batch scale.

Industry compliance standards

• Good Manufacturing Practice (GMP) for APIs (ICH Q7)
• US Food and Drug Administration 21 CFR Part 211
• European Pharmacopoeia quality requirements for starting raw materials
• ICH Q3A/B guidelines for impurities and residual solvents

Typical usage ratio

• Ranging from 0.6 to 1.1 molar equivalents relative to target substrate, with precise dosing controlled by target yield and desired selectivity

Downstream process integration

• Introduced during regulated halogenation steps in multi-step synthesis, followed by purification via liquid-liquid extraction or crystallization before downstream functionalization or coupling

Final product types

• Butyrate-based anticonvulsant intermediates
• Cardioactive pharmaceutical building blocks
• API precursors requiring dibromo functionalities

2. Agrochemical Intermediate Manufacturing

Engineers in agrochemical production rely on this dibrominated ester as a key intermediate for synthesizing select herbicides and insecticides where controlled bromine introduction into the carbon backbone enables subsequent derivatization. Its stability during storage and reactivity under selective conditions make it favored for continuous or batch processes requiring exacting impurity management, particularly in the development of moieties for cereal crop protection or soil treatment additives. Formulators can adjust loading based on the bromination target and conversion efficiency in downstream settings.

Industry compliance standards

• FAO/WHO International Code of Conduct on Pesticide Management
• REACH Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation (EC) No 1907/2006
• ISO 9001:2015 Quality Management Systems (applicable to formulation and traceability)

Typical usage ratio

• 0.2% – 1.4% w/w in intermediate synthesis, adjusted to process scale and target conversion rates per batch

Downstream process integration

• Dosed as a core reactant in closed reactor systems during initial condensation and bromination stages, followed by sequence steps such as hydrolysis, esterification, or amide formation, tailored to specific pesticide actives

Final product types

• Brominated herbicide intermediates
• Key building blocks for non-systemic insecticides
• Soil fumigant additive components

3. Fine Chemical Synthesis and Specialty Intermediates

Producers of fine chemicals employ Ethyl 2,3-Dibromobutyrate for constructing specialized molecular architectures—particularly as an electrophilic partner in small-scale custom synthesis, where precise dibromination influences reactivity profiles for subsequent steps in dyes, photographic chemicals, and performance additives. Its application emphasizes high control over reaction conditions and end-use molecular integrity, especially for specialty batches where downstream integration into organic synthesis chains is critical to performance targets or regulatory compliance.

Industry compliance standards

• ISO 9001:2015 for process documentation and traceability
• Responsible Care® chemical safety management protocols
• National chemical substance inventory regulations for end-use registration (e.g. US TSCA, EU REACH)

Typical usage ratio

• 0.5 to 2.5 mol% depending on end reaction selectivity, downstream conversion goals, and presence of secondary electrophiles

Downstream process integration

• Blended into batch reactors during catalyst-driven alkylation or halogen exchange reactions, with isolation of targeted intermediates via distillation, column chromatography, or aqueous work-up depending on process

Final product types

• Dye intermediate precursors for high-stability colorants
• Brominated building blocks for specialty additives
• Photoresist agent constituent intermediates

4. Organic Synthesis Reagent Supply for Contract Research

Many contract research organizations (CROs) and custom synthesis workshops use this compound as a derivatization and scaffold-modifying agent during R&D for reference compound libraries, especially involving halogenated structures for mechanism-of-action studies. Researchers manage dosing with careful attention to stoichiometry and impurity control, illustrating the importance of reliable technical documentation and batch homogeneity. Working under international laboratory best practices, technical teams often leverage its known reactivity profile in early-phase discovery and structure-activity relationship experiments that feed into later scale-up.

Industry compliance standards

• ISO/IEC 17025 laboratory accreditation
• OECD Good Laboratory Practice (GLP) guidelines
• Controlled Substances Act compliance where applicable for research use

Typical usage ratio

• 0.1 mmol to 10 mmol scale in library synthesis, prepared under inert or anhydrous conditions, determined by structure diversification requirements

Downstream process integration

• Incorporated at early derivatization or scaffold customization step, followed by immediate analysis and purification for submission to biological or analytical assay workflows

Final product types

• Reference standard compounds
• Custom intermediate panels for structure-activity studies
• Experimental building blocks for lead discovery pipelines